Bioventix PLC Stock OTC Markets
Stocks
BVNXF
GB00B4QVDF07
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
OTC Markets
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-.--% | - |
| 03-30 | BioVentix confident on future despite profit decline in first half | AN |
| 03-30 | WINNERS & LOSERS: boohoo to beat view; Abingdon Health wins deals | AN |
| Market Cap | 78.37M 106M 91.71M 86.18M 147M 10.15B 150M 1.01B 395M 5.08B 399M 390M 16.9B | P/E 2026 * |
11.2x | P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 73.48M 99.55M 85.98M 80.79M 138M 9.52B 140M 947M 370M 4.77B 374M 366M 15.84B | EV / Sales 2026 * |
5.88x | EV / Sales 2027 * | - |
| Free-Float |
92.29% | Yield 2026 * |
10% | Yield 2027 * | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Peter Harrison
CEO | Chief Executive Officer | 67 | 23/12/2003 |
| Director of Finance/CFO | 67 | 01/07/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Peter Harrison
BRD | Director/Board Member | 67 | 25/11/2010 |
Ian Nicholson
CHM | Chairman | 66 | 01/11/2004 |
| Director/Board Member | 67 | 01/07/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 106M | |
| -1.78% | -1.68% | +1.99% | +13.84% | 48.42B | |
| +0.85% | -0.70% | +465.55% | +579.03% | 43.66B | |
| -2.40% | -0.23% | +12.20% | +70.22% | 39.51B | |
| -2.01% | -0.85% | +24.95% | +7.51% | 38.95B | |
| -0.50% | +0.85% | +20.60% | +49.65% | 32.61B | |
| -0.59% | -2.06% | +26.13% | +117.79% | 16.15B | |
| +0.38% | -3.23% | - | - | 16.32B | |
| +0.49% | +0.92% | +4.32% | +22.16% | 14.16B | |
| -0.43% | +4.70% | +79.75% | +29.11% | 13.37B | |
| Average | -0.60% | +0.49% | +79.44% | +111.17% | 29.24B | |
| Weighted average by Cap. | -0.91% | +0.59% | +97.63% | +134.68% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 12.5M 16.93M 14.63M 13.74M 23.5M 1.62B 23.89M 161M 62.97M 811M 63.58M 62.2M 2.69B | - |
| Net income | 7.11M 9.64M 8.32M 7.82M 13.37M 921M 13.59M 91.63M 35.83M 461M 36.18M 35.39M 1.53B | - |
| Net Debt | -4.89M -6.63M -5.73M -5.38M -9.2M -634M -9.35M -63.05M -24.65M -317M -24.89M -24.35M -1.06B | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BVXP Stock
- BVNXF Stock
Select your edition
All financial news and data tailored to specific country editions
